急急忙忙 发表于 2025-3-23 13:08:15

To Play by the Rules of the Gameical association of miRNA inhibitors and their targets in the context of the Argonaute complex in vivo, providing unprecedented insight into the physiological interactions of anti-miRs and the miRNA machinery.

Morose 发表于 2025-3-23 14:45:54

,Einwendungsmöglichkeiten des Zahnarztes,termine if a compound is able to impair the loading of miRNAs on AGO2 protein. Here, we describe these two methodologies that we recently used to select a specific compound able to interfere with the AGO2 functional activity and able to improve the retinoic acid-dependent myeloid differentiation of leukemic cells.

tackle 发表于 2025-3-23 19:20:52

http://reply.papertrans.cn/29/2832/283130/283130_13.png

严厉谴责 发表于 2025-3-24 02:00:12

http://reply.papertrans.cn/29/2832/283130/283130_14.png

chapel 发表于 2025-3-24 03:00:59

http://reply.papertrans.cn/29/2832/283130/283130_15.png

galley 发表于 2025-3-24 08:21:27

http://reply.papertrans.cn/29/2832/283130/283130_16.png

jabber 发表于 2025-3-24 13:30:41

Surface Plasmon Resonance: A Useful Strategy for the Identification of Small Molecule Argonaute 2 Pr the film, monitored in real time as a change in the position of the dip in reflected intensity. Since SPR detects mass, the technique is label-free..Here, we describe the use of SPR techniques to study the interaction between Argonaute 2 and small molecular compounds selected by means of high-throughput docking screening.

osculate 发表于 2025-3-24 18:12:58

http://reply.papertrans.cn/29/2832/283130/283130_18.png

有帮助 发表于 2025-3-24 19:42:35

Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOsr lower molecular weight and, thus, more drug-like chemical structure, the novel inhibitor class may show better pharmacokinetic properties than reported oligonucleotide inhibitors, enabling them for potential therapeutic use.

cajole 发表于 2025-3-25 00:14:55

http://reply.papertrans.cn/29/2832/283130/283130_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Drug Target miRNA; Methods and Protocol Marco F. Schmidt Book 2017 Springer Science+Business Media, LLC, part of Springer Nature 2017 drug